Literature DB >> 30800012

Orbital desmoplastic small round cell tumor in an infant.

Amy Huang1, Nishita Patel2.   

Abstract

Desmoplastic small round cell tumor (DSRCT) is a rare, aggressive malignancy that primarily involves the serosal surfaces of the abdomen and pelvis and has a poor prognosis. Orbital involvement is extremely rare. We report the case of a 2-month-old boy who presented with a right infraorbital mass consistent with a DSRCT and causing mass effect and superonasal globe displacement. To our knowledge, this is the first case of orbital DSRCT in an infant.

Entities:  

Mesh:

Year:  2018        PMID: 30800012      PMCID: PMC6380253          DOI: 10.5693/djo.02.2018.10.001

Source DB:  PubMed          Journal:  Digit J Ophthalmol        ISSN: 1542-8958


  15 in total

1.  Desmoplastic small round cell tumor: a potentially lethal neoplasm manifesting in the orbit with associated visual symptoms.

Authors:  Michael Yoon; Komal Desai; Regan Fulton; Kara Bucci; Michael Russin; R Max Conway; Joan M O'Brien
Journal:  Arch Ophthalmol       Date:  2005-04

2.  Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts.

Authors:  L Bonetta; S E Kuehn; A Huang; D J Law; L M Kalikin; M Koi; A E Reeve; B H Brownstein; H Yeger; B R Williams
Journal:  Science       Date:  1990-11-16       Impact factor: 47.728

Review 3.  Updates on the multimodality management of desmoplastic small round cell tumor.

Authors:  Ashwin A Kallianpur; Nootan K Shukla; Suryanarayan V S Deo; Praveen Yadav; Dillip Mudaly; Rajni Yadav; Ramanathan M Palaniappan
Journal:  J Surg Oncol       Date:  2012-01-03       Impact factor: 3.454

4.  EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts.

Authors:  J Zucman; O Delattre; C Desmaze; A L Epstein; G Stenman; F Speleman; C D Fletchers; A Aurias; G Thomas
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

Review 5.  Desmoplastic Small Round Cell Tumor Presenting as an Ocular Mass: Unusual Localization and Remarkable Surgical Approach.

Authors:  H Bengu Cobanoglu; Ehab Y Hanna; Diana Bell; Bita Esmaeli
Journal:  Curr Oncol Rep       Date:  2017-10-18       Impact factor: 5.075

6.  Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.

Authors:  Richard B Womer; Daniel C West; Mark D Krailo; Paul S Dickman; Bruce R Pawel; Holcombe E Grier; Karen Marcus; Scott Sailer; John H Healey; John P Dormans; Aaron R Weiss
Journal:  J Clin Oncol       Date:  2012-10-22       Impact factor: 44.544

7.  Desmoplastic small round cell tumors: prognostic indicators and results of surgical management.

Authors:  R E Schwarz; W L Gerald; B H Kushner; D G Coit; M F Brennan; M P La Quaglia
Journal:  Ann Surg Oncol       Date:  1998 Jul-Aug       Impact factor: 5.344

8.  Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical, and molecular study of 32 tumors.

Authors:  Marick E Lae; Patrick C Roche; Long Jin; Ricardo V Lloyd; Antonio G Nascimento
Journal:  Am J Surg Pathol       Date:  2002-07       Impact factor: 6.394

Review 9.  Primary desmoplastic small round cell tumor in the left orbit: a case report and literature review.

Authors:  Xue-Rui He; Zheng Liu; Jing Wei; Wan-Jun Li; Tao Liu
Journal:  Int Ophthalmol       Date:  2018-01-30       Impact factor: 2.031

10.  Abdominal desmoplastic small round cell tumor: multimodal treatment combining chemotherapy, surgery, and radiotherapy is the best option.

Authors:  Charles Honoré; Koceila Amroun; Laurence Vilcot; Olivier Mir; Julien Domont; Philippe Terrier; Axel Le Cesne; Cecile Le Péchoux; Sylvie Bonvalot
Journal:  Ann Surg Oncol       Date:  2014-10-10       Impact factor: 5.344

View more
  1 in total

Review 1.  Primary desmoplastic small round cell tumor of the submandibular gland: a case report and literature review.

Authors:  Jiayu Zhou; Qingling Li; Baihua Luo; Xiaodan Fu; Chunlin Ou; Xiaomei Gao; Zhijie Xu; Deyun Feng; Keda Yang
Journal:  Diagn Pathol       Date:  2022-01-07       Impact factor: 2.644

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.